The WHO Enhanced Gonococcal Antimicrobial Surveillance Programme (EGASP) identifies high levels of ceftriaxone resistance across Vietnam, 2023
- PMID: 39040039
- PMCID: PMC11260586
- DOI: 10.1016/j.lanwpc.2024.101125
The WHO Enhanced Gonococcal Antimicrobial Surveillance Programme (EGASP) identifies high levels of ceftriaxone resistance across Vietnam, 2023
Conflict of interest statement
We declare no competing interest.
Figures
References
-
- Unemo M., Lahra M.M., Escher M., et al. WHO global antimicrobial resistance surveillance for Neisseria gonorrhoeae 2017–18: a retrospective observational study. Lancet Microbe. 2021;2:e627–e636. - PubMed
-
- van der Veen S. Global transmission of the penA allele 60.001–containing high-level ceftriaxone-resistant gonococcal FC428 clone and antimicrobial therapy of associated cases: a review. Infect Microb Dis. 2023;2:13–20.
-
- Unemo M., Sánchez-Busó L., Golparian D., et al. The novel 2024 WHO Neisseria gonorrhoeae reference strains for global quality assurance of laboratory investigations and superseded WHO N. gonorrhoeae reference strains - phenotypic, genetic and reference genome characterization. J Antimicrob Chemother. 2016 In press. - PMC - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
